Epigenetics Biomarkers

Epigenetic biomarkers is the modifications of the genome with preserved DNA sequence. DNA methylation measurement in cell, it may also be useful in improving early detection by measuring tumor DNA released into the blood. Molecular biomarkers are used routinely in a clinical setting to assess the medical state of patients and in several other medical contexts, including clinical trial endpoints, pharmaceutical development, and basic science research. The clinical validation of epigenetic biomarkers to allow the accurate prediction of the outcome of cancer patients and their potential chemo sensitivity to current pharmacological treatments. A clinical example of a biomarker is plasma glucose.

  • Testis Cancers
  • Urological Cancers
  • Genetic Biomarkers
  • Biomarkers for lung cancer
  • Breast Cancer
  • Ovarian Cancer     
  • Malignant rhabdoid Tumors

 

 

    Related Conference of Epigenetics Biomarkers

    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    June 28-30 2020

    Stroke Summit 2020

    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    September 23-24, 2020

    24th European Biotechnology Congress

    Berlin, Germany
    October 19-20, 2020

    7th Asia Pacific Geriatrics and Gerontology Congress

    Tokyo, Japan
    October 23-24, 2020

    2nd International Conference on Biomarkers and Cancer Targets

    Cape Town, South Africa
    November 23-24, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia
    December 07- 08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 14-15, 2020

    New frontiers in Genetics Research & Advanced Techniques

    San Antonio, USA

    Epigenetics Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in